213 related articles for article (PubMed ID: 33841567)
41. Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for
Brock RM; Beitel-White N; Coutermarsh-Ott S; Grider DJ; Lorenzo MF; Ringel-Scaia VM; Manuchehrabadi N; Martin RCG; Davalos RV; Allen IC
Front Oncol; 2020; 10():843. PubMed ID: 32528898
[TBL] [Abstract][Full Text] [Related]
42. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.
Morishita T; Hayakawa F; Sugimoto K; Iwase M; Yamamoto H; Hirano D; Kojima Y; Imoto N; Naoe T; Kiyoi H
Oncotarget; 2016 Aug; 7(35):56241-56252. PubMed ID: 27494842
[TBL] [Abstract][Full Text] [Related]
43. Chimeric Antigen Receptor-modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model.
Teng R; Zhao J; Zhao Y; Gao J; Li H; Zhou S; Wang Y; Sun Q; Lin Z; Yang W; Yin M; Wen J; Deng H
J Immunother; 2019; 42(2):33-42. PubMed ID: 30586347
[TBL] [Abstract][Full Text] [Related]
44. Intracerebral bispecific ligand-antibody conjugate increases survival of animals bearing endogenously arising brain tumors.
Patrick TA; Kranz DM; Zachary JF; Roy EJ
Int J Cancer; 1998 Nov; 78(4):470-9. PubMed ID: 9797136
[TBL] [Abstract][Full Text] [Related]
45. A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies.
Yang D; Beddows I; Tang H; Cascio S; McGonigal SC; Bai S; Johnson BK; Powers JJ; Acharya R; Bao R; Bruno TC; Soong TR; Conejo-Garcia JR; Shen H; Bility MT; Buckanovich RJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37461447
[TBL] [Abstract][Full Text] [Related]
46. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
[TBL] [Abstract][Full Text] [Related]
47. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
48. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
49. Patient-derived cancer models: Valuable platforms for anticancer drug testing.
Genta S; Coburn B; Cescon DW; Spreafico A
Front Oncol; 2022; 12():976065. PubMed ID: 36033445
[TBL] [Abstract][Full Text] [Related]
50. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
Wang H; Lu J; Tang J; Chen S; He K; Jiang X; Jiang W; Teng L
BMC Cancer; 2017 Mar; 17(1):191. PubMed ID: 28292264
[TBL] [Abstract][Full Text] [Related]
51. Construction of a Humanized PBMC-PDX Model to Study the Efficacy of a Bacterial Marker in Lung Cancer Immunotherapy.
Wu C; Wang X; Shang H; Wei H
Dis Markers; 2022; 2022():1479246. PubMed ID: 36072895
[TBL] [Abstract][Full Text] [Related]
52. Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma.
Yan C; Nebhan CA; Saleh N; Shattuck-Brandt R; Chen SC; Ayers GD; Weiss V; Richmond A; Vilgelm AE
Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509357
[TBL] [Abstract][Full Text] [Related]
53. Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.
Speck T; Heidbuechel JPW; Veinalde R; Jaeger D; von Kalle C; Ball CR; Ungerechts G; Engeland CE
Clin Cancer Res; 2018 May; 24(9):2128-2137. PubMed ID: 29437789
[No Abstract] [Full Text] [Related]
54. Retained or altered expression of major histocompatibility complex class I in patient-derived xenograft models in breast cancer.
Song IH; Kim YA; Lee H; Park HS; Park IA; Sim CK; Lee MS; Gong G; Lee HJ
Immunol Res; 2019 Dec; 67(6):469-477. PubMed ID: 31900802
[TBL] [Abstract][Full Text] [Related]
55. Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells.
Hou X; Du C; Lu L; Yuan S; Zhan M; You P; Du H
World J Surg Oncol; 2022 Feb; 20(1):37. PubMed ID: 35177071
[TBL] [Abstract][Full Text] [Related]
56. PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients.
Kim Y; Kim D; Cao B; Carvajal R; Kim M
BMC Bioinformatics; 2020 Jul; 21(1):288. PubMed ID: 32631229
[TBL] [Abstract][Full Text] [Related]
57. The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.
DeBord LC; Pathak RR; Villaneuva M; Liu HC; Harrington DA; Yu W; Lewis MT; Sikora AG
Am J Cancer Res; 2018; 8(8):1642-1660. PubMed ID: 30210932
[TBL] [Abstract][Full Text] [Related]
58. Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy.
Liu WN; Fong SY; Tan WWS; Tan SY; Liu M; Cheng JY; Lim S; Suteja L; Huang EK; Chan JKY; Iyer NG; Yeong JPS; Lim DW; Chen Q
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32331230
[TBL] [Abstract][Full Text] [Related]
59. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
[TBL] [Abstract][Full Text] [Related]
60. Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
Liu JF; Palakurthi S; Zeng Q; Zhou S; Ivanova E; Huang W; Zervantonakis IK; Selfors LM; Shen Y; Pritchard CC; Zheng M; Adleff V; Papp E; Piao H; Novak M; Fotheringham S; Wulf GM; English J; Kirschmeier PT; Velculescu VE; Paweletz C; Mills GB; Livingston DM; Brugge JS; Matulonis UA; Drapkin R
Clin Cancer Res; 2017 Mar; 23(5):1263-1273. PubMed ID: 27573169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
